Drug developer FibroGen seeks $125 million IPO
October 01, 2014 at 12:21 PM EDT
Drug developer FibroGen Inc., one of the anchors of San Francisco's Mission Bay biotech enclave, wants to raise $125 million in an initial public offering, the company said in a Securities and Exchange Commission filing Wednesday...